Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0000729 (abdominal cramps)
 531 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

One hundred eighty pregnant patients, 17 to 39 years old (mean (+)/- SEM: 25.1 (+)/- 0.39), with an amenorrhea of 7 to 12 weeks (mean (+)/- SEM: 9.4 (+)/- 0.10), and requesting a therapeutic abortion, were selected according to general good health and gave their informed consent to the study. Mifepristone (RU-486; Roussel UCLAF, Paris, France) an antiprogestin steroid, was administered at random in doses of 0, 50, 100, 200, 400, or 600 mg. Clinical evaluations and measurements of cervical dilatation were done before the study and repeated at 24 hours after administration of Mifepristone and at 48 hours, at which time the aspiration was performed. Significant increases in cervical dilatation were observed at 48 hours with all doses of Mifepristone above 50 mg. The increases were significantly greater in patients with a gestational age greater than 10 weeks than in those less than 10 weeks' gestational age. Parity had no influence on cervical dilatation at 48 hours. Bleeding was observed significantly more often with 100 to 600 mg doses of Mifepristone than with 0 to 50 mg. No influence of gestational age or parity on bleeding could be detected. Abdominal cramps were reported more frequently with 200, 400, and 600 mg of Mifepristone at 48 hours and their occurrence appeared to parallel cervical dilatation.
 ...
PMID:The effects of RU-38486 on cervical ripening. Clinical studies. 230 19

Eight patients with postprandial hypotension and orthostatic hypotension were treated with the somatostatin analogue SMS-201-995. Low doses of this drug (0.2-0.4 microgram/kg) raised the blood pressure after breakfast in all six patients with postprandial hypotension. 60 min after breakfast the mean sitting blood pressure was 35 +/- 10 (SEM) mm Hg higher after administration of SMS-201-995 0.4 microgram/kg than after placebo (p less than 0.001). Larger doses (up to 1.6 micrograms/kg) raised upright blood pressure during the postprandial period in five of seven patients. Before therapy three patients were unable to stand after eating; after an injection of SMS-201-995 0.8 microgram/kg at the beginning of breakfast they were able to walk for 35-100 min. The duration of therapeutic effect of each injection was 3-6 h. Treatment was followed by abdominal cramps and nausea in two patients with gastroparesis diabeticorum. SMS-201-995 holds promise as a treatment for postprandial hypotension and orthostatic hypotension.
 ...
PMID:Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995. 287 21

Somatostatin analogs have been shown to be effective for the treatment of TSH-secreting pituitary adenomas. However, their use in this indication is limited by the fact that available analogs require several daily sc injections. The present study was performed to evaluate the effects of a slow release formulation of the somatostatin analog lanreotide (SR-L) on both hormone secretion and tumor size and to assess the tolerance in a series of thyrotropinomas treated for 6 months. Eighteen patients with hyperthyroidism related to a TSH-secreting pituitary adenoma, evidenced by pituitary magnetic resonance imaging, were studied. After a basal assessment, each patient received 30 mg SR-L, im, every 14 days for 1 month. Then, according to the free T3 (fT3) plasma level measured, 9 of 18 patients were injected twice monthly, and 7 of 18 patients received SR-L every 10 days for 5 additional months. One patient was dismissed from the study in month 1 of the study for side-effects and another in month 3 for noncompliance to the protocol. Clinical and biological evaluations (plasma TSH, free alpha-subunit, fT4, fT3, and lanreotide levels) were performed before and in months 1, 3, and 6 of treatment. Pituitary magnetic resonance imaging and gallbladder ultrasonography were performed both at entry and at the end of the study. Clinical signs of hyperthyroidism improved within 1 month in all 16 evaluable patients. Mean (+/- SEM) plasma lanreotide levels reached 1.11 +/- 0.43 and 1.69 +/- 0.65 ng/mL in month 3 using 2 and 3 injections/month, respectively, then remained stable until the end of the study. During therapy, the plasma TSH level decreased from 2.72 +/- 0.32 to 1.89 +/-0.27 mU/L (P < 0.01), with parallel significant changes in free alpha-subunit. During the same period, plasma fT4 and fT3 levels decreased from 37.9 +/- 2.9 to 19.7 +/- 2.3 pmol/L (P < 0.01) and from 14.6 +/- 1.1 to 8.3 +/- 0.8 pmol/L (P < 0.01), respectively. No statistically significant change in mean adenoma size was observed after 6 months of treatment. Side-effects, including pain at the injection point, abdominal cramps, and diarrhea, were mild and transient and did not lead to interruption of the treatment. No gallstones occurred during the study. SR-L appears to be able to suppress clinical signs of hyperthyroidism in our series of patients with TSH-secreting pituitary adenomas. The analog also reduces plasma TSH and thyroid hormone levels, which were normalized in 13 of 16 cases. The effect was maintained throughout the treatment using 2 or 3 SR-L injections monthly without any problem of tolerance. We conclude that SR-L is a safe and effective treatment of thyrotropinomas and avoids the drawbacks of the modes of administration of other somatostatin analogs, given three times daily.
 ...
PMID:Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. 1077 Jan 86

Psychopharmacological properties of crude extract and essential oil of Lippia multiflora (Lm), a verbenacea of african traditional pharmacopea were investigated in rat using classical methods. The extract of Lm is constituted by an infusion of dried leaves. The essential oil is obtained by hydrodistillation of the dried leaves of Lm with a yield of 0.6%. A dilution of 1% is realised with distilled water and the dose of 2 ml/kg of this solution was chosen for this study. The wistar rats of both sexes weighting between 150 and 250 g are used. Animal's behaviour is observed macroscopically for 12 hours. The spontaneous motor activity is appreciated by method of Martin et al. slightly modified. The number of squares jumped by animals in a rectangular cage is determined in ten minutes. The traction test which measures the time necessary for restoration of posterior paws of rat on metallic bar and the duration of pentobarbital sleeping are used for evaluation of muscle relaxant and sedative effects, respectively. The effects of the two preparations of Lm on apomorphin stereotypies and hypothermia are used to investigate the eventual neuroleptic or antidepressant activity. Analgesic property is evaluated by using acetic acid method. The results are expressed as mean +/- SEM. Data are analysed by using the Dunnett's test. A probability level of 0.05 or less was considered to be stalistically significant. The two preparations of Lm at the doses used are well tolerated by rats. No macroscopic difference is observed in behavioural of control and treated groups. Crude extract and essential oil:--does not modify a spontaneous motor activity: control: 45.00 +/- 5.63; crude extract of Lm: 31.00 +/- 5.63; essential oil of Lm: 28.00 +/- 7.62; diazepam 4 mg/kg: 23.80 +/- 5.27 (P < 0.05);--caused an increase of the time necessary for the restoration of paws on the metallic bar in the traction test: control 1.20 +/- 0.25 sec; crude extract of Lm 5.60 +/- 0.57 sec (P < 0.01), essential oil of Lm. 3.60 +/- 0.57 sec (P < 0.01) diazepam 3.60 +/- 0.57 sec (P < 0.01). The differences between the results obtained with crude extract, essential oil and diazepam are significant;--caused a reduction of abdominal cramps induced by acetic acid, control: 26.80 +/- 0.41; crude extract of Lm: 17.00 +/- 1.45 (P < 0.01); essential oil of Lm: 9.20 +/- 1.91 (P < 0.01) and acetylsalicylic acid (Aspegic*) 25 mg/kg 5.40 +/- 1.25 (P < 0.01). The differences is significant between essential oil and crude extract (P < 0.05) but no significant difference is observed between essential oil and acetylsalicylate of lysin. No activity of the two preparations is observed on apomorphin stereotypia and hypothermia comparatively with haloperidol 4 mg/kg and clomipramin 16 mg/kg respectively. Those results confirm the tranquillizer and analgesic activities of Lm and reveal that the crude extract would be more muscle relaxant and the essential oil more analgesic.
 ...
PMID:[Psychopharmacological properties of crude extract and essential oil of Lippia multiflora]. 1168 58